-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VMaZwr6Gdq+JuSRNUZ6Jm6PeVtkDgzKjTooN2yTHWqjFfLOz+i80sFFz8Ejxp+6g HX448NITIbdISBI2I/ilAA== 0000000000-06-042093.txt : 20061020 0000000000-06-042093.hdr.sgml : 20061020 20060830155657 ACCESSION NUMBER: 0000000000-06-042093 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060830 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 PUBLIC REFERENCE ACCESSION NUMBER: 0001125282-05-001681 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C@P(#`@;V)J/#PO2%LU,38@,34T72],:6YE87)I M>F5D(#$O12`T,S`T+TP@,3$U-#4O3B`Q+T\@.#,O5"`Y.#DX/CX-96YD;V)J M#2`@("`@("`@("`@("`@("`@("`@("`@#0IXF4@.3$O4')E=B`Y.#@W+UA29693=&T@-C')E9@T*,`T*)25%3T8-"B`@(`T*.#(@,"!O8FH\/"],96YG=&@@-S$O1FEL M=&5R+T9L871E1&5C;V1E+T,@.#DO3"`W,R]3(#,X/CYS=')E86T-"GC:8F!@ M8&=@8%[```0\TQA0`1,0LS!P-#`AB;%#,0.##P.W8-NQ-;,8W;0<8,I%UD"U M60`Q(P.#@!F$9BF#Z`8(,`!_+`=4#0IE;F1S=')E86T-96YD;V)J#3DP(#`@ M;V)J/#PO4VEZ92`X,"],96YG=&@@,C(O1FEL=&5R+T9L871E1&5C;V1E+T1E M8V]D95!A%LW(##0IE;F1S=')E86T-96YD;V)J#3@Q(#`@;V)J/#PO4&%G97,@ M-"`P(%(O5'EP92]#871A;&]G+TQA;F'1=+T5X=$=3=&%T93P\+T=3 M,"`X.2`P(%(^/CX^+U-T7!E+U1R=654>7!E+T9O;G1$97-CRTW=YW8ZFX)%I2Z4+P9?PI3^$BS>I\/4G&^0<8-1HR2O<;]9.HW=!%B2):4\4''94< M0()(3V9YKS M;+1SZ+&93-EX\R-(:=:?FCZ-DDI\88H-_,6Y@M.RNBNK=&,P%>QR^Q#T M0W]^=]7JB%#)N(_Y+_#.%*9*5ZAE6]1F%13=G[S6.$;93T/=_JFA,2-4,2&] MEV?I]]S:=KU,*UL_TLQL-WF6KNHC>%]D85<'\MRZ5^X\+9_KCV)"-9.>2+\6 M!N;EO:G@%%&8Z@C9T[%Y=I<6.Z7]A<"E4HST=&K2D$8;8O<>8HEZ*1" MHMSGV;7T'ZJU*KF2>$<(HRT<2FW)][GY!8V>\ABQ7)35 M&AO)]`/<8*`O\AJ1P&>35G!>+,P"SDQFUE^1T8*Y[B##^*(PO@/8(+3KG5P_ MP8FL+;M2D6:QL[_G)_Q6&P;%?UW+X? M;J3M?"=XG\W<*Z)^I_WFW+19&O@7X6!)!./< M=&A`DY=Q2N!0W@ZNSSF%WJ%[``CZ?[R#';!%P!3!HX'PY73G%==\=VQB![HI M<*I@+V42Q<:"(S@;8A*/]C!)\!<%BVMMNYM\FG[V#/"Q)(`O35DD<,X+`@@4 M[*%6P&-)(D7E\)@J!H;``UH!5\A#-*WAX9DM%U?5LTGPE3.L#[@F6%UQMQB` MN/\@UZ*1RF9%--S]Q,!Y[A#F>?.(TY,V&9?C>0E=;NNY79(,/* M;065P9YX#^6-RX+T:XDOV73!MVI??>TYT.6.W3@A1>FIX(9#_FA0Y([H4P%3 M1IB2=IA9((:;B1QO)VQ^0QW&'IU\/G0]$_8#X_$NWDQMB$.4W::M[\9A-,13;.<9%Z M7$Q<8F;VR@;5+95_UERM_-6#?_/(+T&/RL#`&@*I;)MFOD\'C9?]PVF?/(E] M5#%_4@O+VW]2;>4)B9,,X\/B#CVN[L1R'."0V[H;FTOO\28V:^MJC5J=Q]_: MA8\W_MDW?[,;Q=I_7OJK8E^D^NM@'UJJ<-QD0G71-H@:[F0=Y=L.A@9T%^UM MB\\M)UY80[W4"^NR<]GYX-1_L.PXHJ'LC;TIGIC^GP`#`,,.ES$-"F5N9'-T M7!E+T9O;G0O16YC;V1I;F7!E+U1R=654>7!E+T9O M;G1$97-C7!E+T9O;G1$97-C'1'4W1A=&4O4T$@9F%LE559&:U4K M[P*>E`].&:-\LLI8E6Q4!@/:P_6P-7S$F:"5P:/5&$RP`33X<\"8&C9&91'B M\6$-;/3*8BH@R((O@-X"&FU2%GPQPP=?(A]\B7RB=/#!EVNK'/AJGY0SH-;P M$:)C5LXA!9(ZI##)*^S#6H`4J-=;@:J34VC*7YX)4'GZ_A@R]X M^.`+Y(,OD@^^F.&#+R&)IR4F^.#+V(0'7X:/DM@:?@!?'>'3DE$T%-3I`!^I M44@5`BQ`(<+6\+$EBT6AA`Z)%$*=K9.*&EM#$:*!Q6`$G\OPP>>Q']J*1](( M/I^-0LE=0/TC^`(V0:4)"?-4"FT4'M&6J!+X$HJ(%KB$?B;P912=2I6QB`2^ MC/TF\-58=`)?G8-*&25#TVGK&D5X_;I:WF]*M1B'W?6X'$JYZ/NQFD-16EU4 M1^MFN_W0;"`MUZ$9Q;/+)Y9/+-X9O',XIDE,$M@EL`L M@5D"LP1F"1/+Q^I<33S5HEJ4ZW$JYVD_W#5K:N)#@4]W=]M+3:>=,-/0V6Y< MMQU:NVFZZK?NI@Q/+A-4Y]4273OLOU1OVC^JXZ&Y*_P$#73]6!"'C[?=S9.S M^-1`+L?M:C>4ZJ0CRF=#R[,#_!^1/:$'^CC>CQSO1Q:[31FVUT.[&7DYB]W5 M,W<N='5PF3+K[^A1+?M+8?$XL%+9/4IPCJ,/5)*B+*&B%.4(%:0H3R@O105" M.2DJ$LI*44D0FRF#D6:H":7%O25)Q%H,(TU$N9*L))BT$,6Z,R2&*!:>(35$ ML?(,R2&*I6<2P:3:NS3YX?:Q^B,QB'5H(!-Z:YF^Y/=W&'T%?7-U?W>0IUZ+ ME67I`@AB95DG"?:2X"`)CI)@R>FV61)<2^Y..LM!?"B=D01+3K"3]-))>NDD MO71T1H/X(G&2KCI)5YVDJUY+@B6]]))>>DDO_5_OY1E^1-S3.R&]LI[@=;8; MT;!76CAYL&Y77?7K;CNVM_>BZ<-F6_AUM[T=5?@[J?^E:;S(BY"+L1D>JFF# M?:6_!_QYP?][@G^TLC_VZGX?VK'M5A_ZFU*]'Y97SY:KL5C(X1OOB6V*HU]2 MU^6PW/9#F>8G_^!V+,-C^!-Z-OLJP`"O:N.X#0IE;F1S=')E86T-96YD;V)J M#3(@,"!O8FH\/"].=6US6S`@,R`P(%)=/CX-96YD;V)J#3,@,"!O8FH\/"]3 M+T0^/@UE;F1O8FH--"`P(&]B:CP\+T-O=6YT(#$O2VEDFMC.60G/SX*/#]A9&]B M92UX87`M9FEL=&5R&UL;G,Z M>#TG861O8F4Z;G,Z;65T82\G('@Z>&UP=&L])UA-4"!T;V]L:VET(#(N.2XQ M+3$S+"!F&UL M;G,Z:5@])VAT='`Z+R]N&UL;G,Z<&1F>#TG:'1T<#HO+VYS+F%D;V)E M+F-O;2]P9&9X+S$N,R\G('!D9G@Z0V]M<&%N>3TG4V5C=7)I=&EE#I3;W5R8V5-;V1I9FEE9#TG1#HR M,#`V,#@R.3$U-30P,B&%P.D-R96%T M;W)4;V]L/2=!8W)O8F%T(%!$1DUA:V5R(#8N,"!F;W(@5V]R9"<@>&%P.DUO M9&EF>41A=&4])S(P,#8M,#@M,S!4,34Z-38Z,C$M,#0Z,#`G('AA<#I#&UL;G,Z>&%P M34T])VAT='`Z+R]N&%P+S$N,"]M;2\G('AA<$U-.D1O M8W5M96YT240])W5U:60Z,3)A,S@U-&,M-3!E,2TT9C,P+3@U,C$M9F9A-F9F M,C)A.3,Q)SX\>&%P34TZ5F5R&UL;G,Z9&,] M)VAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UL.FQA;F<])W@M9&5F875L="<^,3DS-"!!0U0@15A!34E.051)3TX@4D50 M3U)4("`@(#PO'!A8VME="!E;F0])W&-H86YG92!#;VUM:7-S:6]N*2]3;W5R8V5-;V1I M9FEE9"A$.C(P,#8P.#(Y,34U-#`R*3X^#65N9&]B:@UX -----END PRIVACY-ENHANCED MESSAGE-----